Telehealth Innovation, Digital Medicine & EO Care: Transforming Clinician-Guided Therapy
Telehealth Innovation, Digital Medicine & EO Care
The Boston Globe Feature & Scalable Clinician-Guided Therapeutics
Front-page coverage in The Boston Globe spotlighted how Dr. Benjamin Caplan and inaugural Massachusetts Cannabis Control Commission Chairman Steven Hoffman joined forces to launch EO Care: the nation’s first digital health platform connecting patients with algorithmically tailored, physician-supervised cannabinoid care.
Former Massachusetts Cannabis Czar Joins Dr. Caplan’s EO Care
Read The Boston Globe’s investigative profile detailing why former state regulator Steven Hoffman chose EO Care to solve the nationwide clinical guidance crisis in medical cannabis.
Read Boston Globe Feature ↗The Four Pillars of Clinician-Guided Digital Care
How algorithmic intelligence and medical oversight replace dispensary guesswork.
Real-Time Inventory Lab Ingestion
EO Care ingests live dispensary Certificates of Analysis (COAs), reading exact cannabinoid concentrations (THC, CBD, CBN, CBG) and dominant terpene profiles rather than arbitrary strain names.
Personalized Therapeutic Titration
Proprietary clinical decision algorithms compute individualized milligram starting doses, delivery routes (sublingual, vaporized, oral), and diurnal dosing schedules tailored to patient symptom logs.
Clinician-in-the-Loop Safeguards
Automated algorithmic recommendations are actively monitored by licensed physicians to cross-check against prescription pharmaceutical contraindications and liver enzyme sensitivities.
Affordable National Access
Democratizing expert medical cannabis oversight at a fraction of traditional clinical consult costs ($10–$15/month), ensuring equity across chronic pain, geriatric, and veteran communities.
Explore Related Academic & Clinical Channels
Continue exploring Dr. Caplan’s Harvard Business School lectures, broadcast anthologies, and topic directories.
